Trial intelligence / Profile preview

Astragalus membranaceus in IgA nephropathy: effects on Cosmc expression and IgA glycosylation

TCTR20140515001Completed

Sponsor
West China Hospital of Sichuan University
Start
Jan 2013
Countries
1
01

Overview

Trial of astragalus membranaceus in IgA nephropathy (IgAN), sponsored by West China Hospital of Sichuan University. Primary endpoint: Cosmc gene expression. Started Jan 2013; status: completed.

02

Drugs

astragalus membranaceus
03

Conditions

IgA nephropathy (IgAN)

Beyond the preview

Go deeper on TCTR20140515001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20140515001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call